A Prospective Research Investigation of Ischemia Using MCG

ID#: NCT06481943

Age: 18 years - 66+

Gender: All

Healthy Subjects: No

Recruitment Status: Recruiting

Start Date: July 11, 2024

End Date: April 01, 2026

Contact Information:
Maggie LeDang
408-981-8754
Summary: PRISM is a prospective, pilot research study that aims to systematically characterize the usefulness of CardiAQ MCG, a bedside magnetocardiography device, in the evaluation of myocardial ischemia and infarction status.
Eligibility:

Inclusion Criteria:

- Scheduled to undergo a diagnostic angiography or revascularization procedure for the diagnosis or treatment of ischemia or acute myocardial infarction

- Ability for participant to comply with study requirements

- Patient consented before the planned, clinically indicated cath-lab procedure begins to allow sufficient time for study related activities

- Written informed consent

Exclusion Criteria:

- Present STEMI

- Pregnant or breastfeeding

- Having an active atrial fibrillation episode as seen on most current 12-lead ECG

- Active thoracic metal implant

- Poor access to follow-up
Find a Clinical Trial Find Cancer Clinical Trials